TFF Pharmaceuticals Inc Science Day Transcript
Good afternoon, and welcome to the TFF Pharmaceutical Science Day. (Operator Instructions)
As a reminder, this webinar is being recorded, and a replay will be made available on the TFF website following the conclusion of the event. I'd now like to turn the call over to your host, Dr. Dale Christensen, TFF Pharmaceuticals Clinical Development Head. Please go ahead, Dale.
Hello. I'd like to thank everybody for joining our call today to hear about the exciting work that TFF has been doing in the development of inhaled voriconazole, as well as our COVID approach with an inhaled antibody that has been partnered with Augmenta Bioworks and Dr. Chris Emig. For formalities, please read the safe harbor statement, and these slides will be online after the call. Again, thank you for joining today. And I would like to give an outline of what the presentation order will be Dr. Schwarz will first present our work on the voriconazole inhalation powder. And then Dr. Emig will speak about the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |